IASIS PHARMA proudly announces the exclusive sponsorship of a clinical trial on the effect of Chios Mastic on blood vessels’ functionality and inflammation”. The research center conducting the study is “Alexandra” General Hospital, the results of the study are expected to be announced the last quarter of 2016.
IASIS PHARMA proudly announces the exclusive sponsorship of a clinical trial on the effect of Chios Mastic in capsules on Helicobacter Pylori. The main research center is “Laiko” Hospital of Athens. Read more about the study's latest findings here
MAKEDONIA PALACE, THESSALONIKI, 26-28/05/2016 ΙΑSIS PHARMA demonstrated its strong interest in Cardiology by participating in the 15th Cardiology Congress of North Greece, that took place at the Macedonia Palace Hotel, Thessaloniki, 26-28 May 2016 under the auspices of the Cardiology Society of North Greece (Κ.Ε.Β.Ε). Τhe Congress is the main Scientific event of Κ.Ε.Β.Ε. addressed not [...]
HYATT REGENCY HOTEL, THESSALONIKI, 23/04/2016 IASIS PHARMA participated, as it consistently does every year, in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the HYATT REGENCY HOTEL Thessaloniki, on 23 April 2016. IASIS PHARMA stand was visited by the increased majority of Dermatologists where 3 of its major dermatological products [...]
CROWNE PLAZA HOTEL, ATHENS, 12/04/2014 IASIS PHARMA successfully participated in the Annual Day Conference of the Endoscopy Chapter of the Hellenic Society of Gastroenterology at the CROWNE PLAZA Hotel in Athens, on April 12 2014. During the Conference the latest developments in the areas of diagnostic and interventional endoscopy, that represent a significant part of a [...]
ATHENS, 01-02/04/2016 The kick-off meeting of the research program under the distinct title “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) programs was successfully organized on 1-2 April 2016. The specific program aims to exploit the aromatic plants’ by-products such as the Chios Mastic for the purpose of developing novel pharmaceutical products. The meeting took place [...]
NATIONAL CENTER FOR SCIENTIFIC RESEARCH “DEMOCRITOS”, 01-02/04/2016 IASIS PHARMA successfully participated in the 21st Hellenic Conference for Helicobacter Pylori and Other Infections of the Peptic System that took place at the National Center for Scientific Research “Democritos”, 1-2 April 2016 organized by the Hellenic Society for the Study of H pylori. Congress invitees included distinguished gastroenterologists [...]
THE MET HOTEL, THESSALONIKI, 23/03/2016 A scientific lecture under the title: “The role of Chios Mastic Gum on functional dyspepsia and helicobacter pylori. A novel Pharmaceutical approach” was successfully organized on Wednesday 23 March 2016 20:00 at the «THE ΜΕΤ HOTEL», in Thessaloniki. The event was addressed to GPs. The main speaker Dr. Hr. Zavos, specialized gastroenterologists-hepatologist, [...]
BRUSSELS, 10/11/2015 IASIS PHARMA proudly announces its participation in a program of H2020. The program Horizon 2020 is the financing framework of the EU for research and Innovation that will cover the period 2014-2020, with a budget of approximately 80 billion Euros. The program supports the strategy "Europe 2020" that promotes research and innovation as the [...]
ATHENS LEDRA HOTEL, ATHENS, 13/12/2014 IASIS PHARMA participated, as it consistently does every year, in the Annual Winter Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the ATHENS LEDRA HOTEL, in Athens, on 13 December 2014. IASIS PHARMA stand was visited by a high number of Dermatologists where three (3) [...]
